MENU
+Compare
CADL
Stock ticker: NASDAQ
AS OF
May 8, 04:59 PM (EDT)
Price
$4.75
Change
+$0.21 (+4.63%)
Capitalization
223.68M

CADL Candel Therapeutics Forecast, Technical & Fundamental Analysis

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer... Show more

CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CADL with price predictions
May 07, 2025

CADL's RSI Indicator ascends from oversold territory

The RSI Indicator for CADL moved out of oversold territory on April 11, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In of the 19 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for CADL just turned positive on April 22, 2025. Looking at past instances where CADL's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CADL advanced for three days, in of 179 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CADL as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for CADL moved below the 200-day moving average on May 06, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CADL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CADL entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.409) is normal, around the industry mean (14.238). P/E Ratio (0.000) is within average values for comparable stocks, (62.770). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.866). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.967).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CADL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CADL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CADL is expected to report earnings to fall 6.35% to -37 cents per share on May 08

Candel Therapeutics CADL Stock Earnings Reports
Q1'25
Est.
$-0.37
Q4'24
Missed
by $0.10
Q4'23
Missed
by $0.20
Q3'23
Missed
by $0.10
Q2'23
Missed
by $0.03
The last earnings report on March 13 showed earnings per share of -40 cents, missing the estimate of -30 cents. With 701.43K shares outstanding, the current market capitalization sits at 223.68M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
42
Web
https://www.candeltx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDGCX19.07N/A
N/A
Fidelity Advisor Dividend Growth C
SRIDX13.14N/A
N/A
Gabelli SRI I
TVRAX16.01N/A
N/A
NAA Allocation Fund A
FIQBX27.45N/A
N/A
Fidelity Advisor Asset Manager 70% Z
AFVZX20.68N/A
N/A
Applied Finance Select Institutional

CADL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-1.09%
CYYNF - CADL
46%
Loosely correlated
N/A
RPTX - CADL
40%
Loosely correlated
+2.26%
INO - CADL
34%
Loosely correlated
+2.92%
MDGL - CADL
33%
Poorly correlated
+1.25%
PRTA - CADL
32%
Poorly correlated
-0.82%
More